Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

admin
Pinned July 21, 2016

<> Embed

@  Email

Report

Uploaded by user
Scientists use light to nuke cancer cells in mice
<> Embed @  Email Report

Scientists use light to nuke cancer cells in mice

David Lumb July 01, 2016
 

Henning Dalhoff / Getty Images

In the great fight against cancer, scientists look for solutions that are both effective and less ravaging than current treatments like chemotherapy. One experimental concept, optogenetics, uses light to reduce or eliminate cancer cells. Researchers at UT San Antonio have devised a method using this school of treatment to attack inoperable or hard-to-reach tumors, which could give options to patients who were considered too high of risk to help.

The technique involves injecting the chemical compound nitrobenzaldehyde into the tumor and waiting for it to diffuse through it. Then a beam of ultraviolet light is aimed at the chemical-filled tumor, which becomes so highly acidic that it basically commits suicide, according to a UT San Antonio press release. In two hours, 95 percent of the cancer cells targeted in the test mice were dead, estimated the researcher.

While still very experimental, this method limits the treatment to a specific area, unlike chemotherapy that affects all cells in the body. Since it only requires an injection it’s also non-invasive, making it appealing for complicated areas like the brain stem or spine. There are others tinkering with optogenetic methods: Tufts University researchers injected frog embryos with genes that produced light-sensitive ion channels in tumor cells that shrunk when exposed to blue light. While both are still far from ready for human trials, they’re promising options for future patients who wouldn’t be treatable today.

(51)